26 years of experience in conducting and leading global Phase II-IV studies in different therapeutic areas with the past 5+ years in Oncology space and working with small to medium sized Biotech’s in leading studies in Phase-I / FIH. Extensive experience in driving study deliveries, third party vendor management, portfolio level partnerships, and people management.
